Skip to content

Compariing the effect of intermittent versus continuous phototherapy for reducing neonatal icter.

Comparing the effect of intermittent versus continuous phototherapy for reducing neonatal hyperbilirubinemia in Besat hospital of Hamedan.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201012255459N1
Enrollment
96
Registered
2011-02-10
Start date
2009-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice from other and unspecified causes

Interventions

Intervention 1: Intermittent phototherapy group received phototherapy for one hour and then one hour off intermittently. Phototherapy units were equipped with 4 special blue tubes (Tosan Co), placed 1
Treatment - Other
Treatment - Drugs
Intermittent phototherapy group received phototherapy for one hour and then one hour off intermittently. Phototherapy units were equipped with 4 special blue tubes (Tosan Co), placed 15-20 cm above th
Continuous phototherapy group (control group) received phototherapy for two hours and then half an hour off. Phototherapy units were equipped with 4 special blue tubes (Tosan Co) placed 15-20 cm above

Sponsors

Hamedan University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: neonate between 2-14 day old, body weight more than 2500 grams, absence of other concomitant diseases, bilirubin between 16mg/dl and 22 mg/dl, obtaining approval letter from the ethics committee Exclusion criteria: body weight under 2500 grams, presence of any concomitant diseases, need to blood exchange, need to intensive phototherapy, gestational age lower than 37 weeks, prolonged icterus (more than 14 day), direct bilirubin more than2 mg/dl

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Indirect bilirubin. Timepoint: 12, 24, 36, 48 hours after beginning of phototherapy. Method of measurement: mg/dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKamran Sabzian

Hamedan University of Medical Sciences and Health Services

k.sabzian@umsha.ac.ir+98 81 1264 0050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026